DCVC Bio key facts
- DCVC Bio is a venture capital firm based in San Francisco, California with 20 tracked portfolio companies.
- Notable positions include Orca Bio, MycoWorks, Umoja Biopharma.
- DCVC Bio has 4 funds on record, raising $1.3B across the 4 that report a size.
- The team roster lists 8 people.
About DCVC Bio
Founded in 2018, DCVC Bio is a venture capital firm headquartered in San Francisco, California. The firm invests in early-stage deep tech startups in the life sciences. These include therapeutics platforms, companies improving agriculture and food systems, and industrial biotechnologies. The firm is a scientists and entrepreneurs supporting companies advancing basic science, generating biological data, iterating with artificial intelligence, and automation. The firm likes teams who are unifying data to transform existing life sciences technologies and speed the development of new ones. This firm is a Registered Investment Adviser (RIA).
DCVC Bio portfolio at a glance
20 portfolio companies are on record for DCVC Bio, including Orca Bio, MycoWorks and Umoja Biopharma.
18 of the 20 carry a recorded valuation.
DCVC Bio funds
4 funds are on record for DCVC Bio, totalling $1.3 billion across the 4 that report a size. The most recent is DCVC Bio III, L.P. (2023 vintage), $400 million.
DCVC Bio team
8 people are on record at DCVC Bio: 2 partners, 2 managing partners, 1 principal, 1 associate and 2 others. Senior names include John Hamer (Co-Founder), Kiersten Stead (Co-Founder) and Anna Fokina (Investment Director). 5 of them have a verified direct contact on file.
Is this your firm? Sign in with your work email to keep it current, or tell us what's wrong.
- ·The top 10 names in the book — of 20 recorded positions
- ·Watchlist + alerts for DCVC Bio's activity
Portfolio
20 companies · priced for members| Company | Industry | Valuation | First invested | Role |
|---|---|---|---|---|
| Orca Bio | — | ▮ | ▮ | ▮ |
| MycoWorks | — | ▮ | ▮ | ▮ |
| Umoja Biopharma | — | ▮ | ▮ | ▮ |
+ 17 more companies · all 20, priced and dated or a free account shows the top 10 names — no card Membership and data by Private Market View | ||||
Funds
4 recorded- DCVC Bio III, L.P.2023$400.0M
- DCVC Bio Opportunity Fund, L.P.2021$350.0M
- DCVC Bio II, L.P.2020$350.0M
- DCVC Bio, L.P.2018$208.0M
$1.3B raised across the 4 funds that report a size
Partners, principals, and the people who answer a pitch. Pro members reveal contacts with credits.
Frequently asked about DCVC Bio
- What companies does DCVC Bio invest in?
- DCVC Bio has 20 recorded portfolio companies, including Orca Bio, MycoWorks, Umoja Biopharma.
- What is DCVC Bio's AUM?
- DCVC Bio manages approximately $1.2B in assets.